Targeting the androgen receptor in hormone-refractory prostate cancer – new concepts

By Eder Iris E   Haag Petra   Bartsch Georg   Klocker Helmut  

Future Oncology, Vol. 1, Iss. 1, 2005-02 ,pp. : 93-101

Future Medicine

Access to resources Recommend Favorite

Prognostic factors for survival in patients with hormone-refractory prostate cancer (HRPC) after initial androgen deprivation therapy (ADT)

By Cho D.   Di Blasio C.J.   Rhee A.C.   Kattan M.W.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 4, 2003-07 ,pp. : 282-291

Elsevier

Access to resources Recommend Favorite

Management Strategies for Hormone-Refractory Prostate Cancer

By Attard Gerhardt   de Bono Johann S.   Parker Christopher C.   Horwich Alan  

American Journal of Cancer, Vol. 5, Iss. 3, 2006-01 ,pp. : 163-169

Adis International

Access to resources Recommend Favorite

Prostate Cancer Cells Increase Androgen Sensitivity by Increase in Nuclear Androgen Receptor and Androgen Receptor Coactivators; A Possible Mechanism of Hormone-Resistance of Prostate Cancer Cells

By Fujimoto Naohiro   Miyamoto Hiroshi   Mizokami Atsushi   Harada Shuji   Nomura Masayoshi   Ueta Yoichi   Sasaguri Takakazu   Matsumoto Tetsuro  

Cancer Investigation, Vol. 25, Iss. 1, 2007-01 ,pp. : 32-37

Informa Healthcare

Access to resources Recommend Favorite

Androgen Receptor Coregulatory Proteins as Potential Therapeutic Targets in the Treatment of Prostate Cancer

By  

Current Cancer Therapy Reviews, Vol. 1, Iss. 2, 2005-06 ,pp. : 175-186

Bentham Science Publishers

Access to resources Recommend Favorite